SCDAA Receives $100,000 Donation from GBT
Funds will be deployed to help SCDAA member organizations (April 2, 2020 – Hanover, MD) Responding to the Sickle Cell Disease... Continue Reading
Sickle Cell Disease Association of America Aims to Raise $100,000 in 10 Days to Address Coronavirus
Raising Money and Giving Grants to Member Organizations in the United States The Sickle Cell Disease Association of America has launched... Continue Reading
NEW – Sickle Cell Disease and COVID-19: Provider Advisory
Download Provider Advisory Download Sub-Saharan African Provider Advisory An Outline to Decrease Burden and Minimize Morbidity March 24, 2020- Sickle cell... Continue Reading
NEW – Health Alert for Patients and Caregivers
DOWNLOAD PATIENT PDF DOWNLOAD PATIENT SUB-SAHARAN AFRICAN PDF April 1, 2020 – COVID-19, the coronavirus disease of 2019 – also known as... Continue Reading
A Health Note From Dr. Biree Andemariam, SCDAA Chief Medical Officer
What You Need to Know About the Coronavirus (COVID-19) With COVID-19 on the forefront of nearly everyone’s minds, SCDAA wants to... Continue Reading
ASH and FDA Unveil New Recommendations to Guide Clinical Development of Sickle Cell Disease Therapies
Joint FDA/ASH Led Initiative Highlights Importance of Using Patient Reported Outcomes and Biomarkers in Clinical Trials to Advance SCD Therapies (WASHINGTON,... Continue Reading
GBT’s Oxbryta™ (voxelotor) tablets is approved for the treatment of sickle cell disease
Oxbryta™ (voxelotor) tablets Now Approved On behalf of GBT, we are happy to share that Oxbryta (pronounced ox-brye-ta) is now approved... Continue Reading
New Hope for a Sickle Cell Cure
How gene therapy is helping children with this devastating disease. By Joy Harrington, Writer When Mr. and Mrs. Jones married and left... Continue Reading
FDA Approves Global Blood Therapeutics Sickle Cell Disease Drug
(Reuters) – The U.S. Food and Drug Administration said on Monday it approved a drug from Global Blood Therapeutics Inc to... Continue Reading
CRISPR Therapeutics and Vertex Announce Positive Safety and Efficacy Data
Nov 19, 2019 CRISPR Therapeutics and Vertex Announce Positive Safety and Efficacy Data From First Two Patients Treated With Investigational CRISPR/Cas9... Continue Reading